Supply chains are networks of logistical facilities such as suppliers, manufacturers, warehouses, distributors, and retailers. These facilities facilitate the movement of raw materials, intermediate products, and finished products. Disruptions in supply chain logistics can lead to shortages ranging from negligible to devastating. For instance, drug shortages can have negative economic and clinical impacts on patients. To effectively assess the risk of supply chain shortages, a method that can represent the supply chain in a suitable format for decision-making analysis and can be automated is necessary. In “A Quantitative Approach to Assess the Likelihood of Supply Chain Shortages,” we defined a methodology to measure the probability of a supply chain’s throughput failure. Based on this methodology, we created the SUpply chain Probabilistic Risk Assessment (SUPRA), a software tool that quantifies the probability of supply chain shortages, as presented in this paper. Using facility failure and flow information, SUPRA outputs the supply chain failure probability and importance measures of the supply chain facilities. We can generate a shortage risk profile from the results. The shortage risk profile, importance measures, and quantified supply chain failure probabilities can inform decision-makers to mitigate and manage supply chain shortages.
Background: Supply chain disruptions from natural hazards, geopolitical tensions, or global events, such as the COVID-19 pandemic, can trigger widespread shortages, with particularly severe consequences in healthcare through drug supply interruptions. Existing methods to assess shortage risks include scoring, simulation, and machine learning, but these approaches face limitations in interpretability, scalability, or computational cost. This study explores the application of probabilistic risk assessment (PRA), a method widely used in high-reliability industries, to evaluate pharmaceutical supply chain risks. Methods: We developed the supply chain probabilistic risk assessment framework and tool, which integrates facility-level failure probabilities and flow data to construct and quantify fault trees and network graphs. Using FDA inspection data from drug manufacturing facilities, the framework generates shortage risk profiles, performs uncertainty analysis, and computes importance measures to rank facilities by risk significance. Results: SUPRA quantified 7567 supply chain models in under eight seconds, producing facility-level importance measures and shortage risk profiles that highlight critical vulnerabilities. The tool demonstrated scalability, interpretability, and efficiency compared with traditional simulation-based methods. Conclusions: PRA offers a systematic, data-driven approach for shortage risk assessment in supply chains. SUPRA enables decision-makers to anticipate vulnerabilities, prioritize mitigation strategies, and strengthen resilience in critical sectors such as healthcare.